Biohaven: Janus Henderson reports 6.4% stake, 6,772,113 shares
Biohaven Ltd. received a Schedule 13G from Janus Henderson Group plc reporting beneficial ownership of 6,772,113 shares of common stock, representing 6.4% of the class as of the event date 09/30/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Biohaven Ltd. received a Schedule 13G from Janus Henderson Group plc reporting beneficial ownership of 6,772,113 shares of common stock, representing 6.4% of the class as of the event date 09/30/2025. The filer reports 0 sole voting and dispositive power and 6,772,113 shared voting and dispositive power.
The filing also states that JHIUS may be deemed the beneficial owner of 6,634,902 shares, or 6.3%, with shared voting and dispositive power and no sole power. The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Janus Henderson disclose about BHVN?
What is the event date for this BHVN Schedule 13G?
What voting and dispositive powers were reported?
Does the filing indicate a passive investment intent?
Which subsidiaries are identified in relation to the BHVN holdings?
AI-generated analysis. How Rhea-AI works. Not financial advice.